1st NHI patient in Taiwan undergoes costly cancer therapy

A cancer patient in her 70s has become the first person in Taiwan to have costly chimeric antigen receptor (CAR) T-cell therapy covered by the National Health Insurance (NHI) system.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)